Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
Jan 31, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-23-008586.pdf
0001104659-23-008586.rtf
0001104659-23-008586.xls
Jan 31, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-23-008594.pdf
0001104659-23-008594.rtf
0001104659-23-008594.xls
Jan 31, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-23-008588.pdf
0001104659-23-008588.rtf
0001104659-23-008588.xls
Jan 25, 2023 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-23-006379.pdf
0001104659-23-006379.rtf
0001104659-23-006379.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 19, 2023 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-23-004841.pdf
0001104659-23-004841.rtf
0001104659-23-004841.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 17, 2023 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-23-004061.pdf
0001104659-23-004061.rtf
0001104659-23-004061.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 13, 2023 SC 13G/A

An amendment to the SC 13G filing

View HTML
0001273087-23-000026.pdf
0001273087-23-000026.rtf
0001273087-23-000026.xls
Jan 11, 2023 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-23-002930.pdf
0001104659-23-002930.rtf
0001104659-23-002930.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 03, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-23-000329.pdf
0001104659-23-000329.rtf
0001104659-23-000329.xls
Jan 03, 2023 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-23-000327.pdf
0001104659-23-000327.rtf
0001104659-23-000327.xls

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
305 Madison Avenue|Morristown, NJ 07960|T: 844-782-ICPT
© 2023 Intercept Pharmaceuticals, Inc.